Results 71 to 80 of about 5,347 (209)

Drug–Drug Interaction Signals for Apixaban‐Associated Haemorrhage in Atrial Fibrillation and Thromboembolic Disorders: A Disproportionality Analysis of the FAERS Database

open access: yesJournal of Interventional Cardiology, Volume 2026, Issue 1, 2026.
Background Apixaban is commonly used in anticoagulation therapy. Its safety profile is associated with polypharmacy and potential drug–drug interactions (DDIs). Current understanding often focuses on canonical metabolic pathways, while other biological factors of haemorrhagic risk remain not fully described.
Zhuang Chen   +3 more
wiley   +1 more source

COMPARATIVE ASSESSMENT OF LARGE ARTERY ELASTICITY IN PATIENTS WITH STABLE ANGINA RECEIVING METABOLIC THERAPY

open access: yesРоссийский кардиологический журнал, 2012
Aim. To assess the effects of metabolic therapy, administered together with standard antianginal treatment, on large artery elasticity and endotheliumdependent vasodilation in patients with stable angina and subsequent heart failure. Material and methods.
O. V. Ilukhin   +5 more
doaj  

Cardiologists' Perspectives on Race-Based Drug Labels and Prescribing Within the Context of Treating Heart Failure

open access: yesHealth Equity, 2019
Purpose: Cardiologists are known to consider patients' race when treating heart failure, but their views on the benefits and harms of this practice are largely undocumented.
Shawneequa L. Callier   +4 more
doaj   +1 more source

HFrEF pharmacological treatment: hydralazine and isosorbide dinitrate

open access: yes, 2018
The use of hydralazine and isosorbide dinitrate in combination with renin–angiotensin blockade and evidence-based beta-blocker therapy is an accepted therapy for heart failure with reduced ejection fraction (HFrEF).
Clyde W. Yancy, Faraz S. Ahmad
core   +1 more source

Design, Synthesis and Biological Evaluation of Nitrate Derivatives of Sauropunol A and B as Potent Vasodilatory Agents

open access: yesMolecules, 2019
A group of nitrate derivatives of naturally occurring sauropunol A and B were designed and synthesized. Nitric oxide (NO) releasing capacity and vasodilatory capacity studies were performed to explore the structure-activity relationship of resulted ...
Lu Lu   +9 more
doaj   +1 more source

Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI

open access: yes, 2000
PURPOSE: In an effort to improve radiotherapy treatments, methods aimed at increasing the quantity of oxygen delivered to tumors were investigated. The aim of this study was to evaluate the effect of one nitric oxide (NO) donor (isosorbide dinitrate) on ...
Bernard Gallez   +11 more
core   +1 more source

Antianginal treatment and quality of life in patients with chronic coronary heart disease

open access: yesКардиоваскулярная терапия и профилактика, 1970
Aim. To assess the effects of various antianginal nitrate therapy variants on quality of life (QoL) in patients with chronic coronary heart disease (CHD). Material and methods.
B. I. Geltser   +4 more
doaj  

Influence of standard and nicotine-reduced cigarette smoke on plasma concentrations of isosorbide dinitrate and its metabolites in rats

open access: yes, 1991
Rats dosed orally with isosorbide dinitrate (1 mg kg−1) were exposed to smoke from standard and nicotine-reduced cigarettes for 8 min using a smoking machine.
Katsushi Furuno   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy